Strasbourg, France

Yves Ruff

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yves Ruff. Retrieved from https://idiyas.com/inventor/yves-ruff-56osa0ov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yves Ruff - Innovator in DNA-Conjugated Molecule Reactions

Introduction

Yves Ruff is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of molecular biology, particularly in the area of DNA-conjugated molecule reactions. His innovative work has led to the development of a unique solid support that enhances the efficiency of these reactions.

Latest Patents

Yves Ruff holds a patent for a solid support designed for use in non-aqueous DNA-conjugated molecule reactions. This solid support comprises a solid body formed from a plurality of polyethylene glycol units, which includes at least one cationic moiety. This invention is crucial for improving the performance of DNA-conjugated reactions, making them more effective and reliable.

Career Highlights

Yves Ruff is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on cutting-edge research and development projects that aim to advance medical science and improve patient outcomes. His expertise in molecular biology and innovative thinking have positioned him as a valuable asset in his field.

Collaborations

Yves Ruff collaborates with Frederic Berst, who is also involved in research and development at Novartis. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in scientific research.

Conclusion

Yves Ruff's contributions to the field of DNA-conjugated molecule reactions highlight his innovative spirit and dedication to advancing science. His patent and work at Novartis AG demonstrate the impact of his research on the future of molecular biology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…